Journal: bioRxiv
Article Title: p53 activity links chromosomal instability to pro-migratory extracellular vesicles
doi: 10.64898/2026.10.06.757210
Figure Lengend Snippet: a. Schematic overview of the experimental design . b. Quantification of mitotic errors in NIH/3T3 cells treated with DMSO, reversine (REV; 75 nM), or doxorubicin (DOXO; 250 nM). Mps1 inhibition by REV compromised spindle-assembly-checkpoint control and increased chromosome-segregation errors. No mitotic events were observed in the DOXO-treated group during imaging; therefore, the frequency of mitotic errors could not be calculated for this condition. c. Single-cell whole-genome sequencing (scWGS) analysis of NIH/3T3 cells treated with DMSO, REV, or DOXO, showing treatment-associated chromosome copy-number alterations. Each row represents one cell, and colors indicate chromosome copy-number states. d. Quantitative PCR analysis of the relative expression of Trp53 , Cdkn1a , Il6, and Lmnb1 in NIH/3T3 cells treated with DMSO, REV, or DOXO. e. Quantification of the percentage of EdU-positive cells and SA-β-galactosidase activity following DMSO, REV, or DOXO treatment. SA-β-galactosidase activity is expressed as integrated density per cell. f. Schematic of the p21–RFP reporter construct, in which TurboRFP expression is driven by the murine Cdkn1a promoter containing p53-binding sites. g. Representative flow-cytometry analysis of RFP expression in NIH/3T3 p21–RFP reporter cells treated with DMSO or REV (75 nM, 96 h), showing reporter-defined p21-RFP HIGH and p21-RFP LOW populations. h. Validation of reporter dependence on p53 using two independently generated Trp53 -knockout NIH/3T3 reporter clones analyzed by flow cytometry. i. Longitudinal characterization of REV-induced p21-RFP HIGH and p21-RFP LOW populations after sorting. RFP fluorescence and EdU incorporation following a 24h pulse was measured on days 1–6 (n = 2 each). p21 protein abundance was assessed by western blot densitometry (n = 1), and SA-β-galactosidase activity was quantified (n = 3) on days 2, 4, and 6. n denotes independent experiments. Data in panels d and e are presented as mean ± SD. SA-β-galactosidase data in panel i are presented as mean ± SD; RFP and EdU plots show the mean and individual values from two independent experiments. Time-course data are presented descriptively without statistical hypothesis testing. Statistical significance was determined using one-way analysis of variance (ANOVA) followed by Tukey’s multiple comparisons test for panels ( d ) and ( e ) (n = 4 independent experiments for panel d ; n = 3 independent experiments for panel e ). Abbreviations: DMSO, vehicle control; REV, reversine; DOXO, doxorubicin. Statistical significance is indicated as follows: *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.
Article Snippet: NIH/3T3 cells were transfected with the p21 promoter–driven TurboRFP reporter plasmid (pTurboRFP-PRL, Addgene #52432) using Lipofectamine 3000 (Thermo Fisher).
Techniques: Inhibition, Control, Imaging, Single Cell, Whole-Genome Sequencing, Analysis, Real-time Polymerase Chain Reaction, Expressing, Activity Assay, Construct, Binding Assay, Flow Cytometry, Biomarker Discovery, Generated, Knock-Out, Clone Assay, Fluorescence, EdU Assay, Quantitative Proteomics, Western Blot, Genomic Sequencing